# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 180


In regulation 221 (amendment of regulation 327 (powers of inspection, sampling and seizure))—
(a) in paragraph (2), for sub-paragraphs (b) and (c) substitute—
“(b) after paragraph (v), insert—
“(va) an EU marketing authorisation;”.”;
(b) for paragraph (3) substitute—
“(3) In paragraph (2)(g), after paragraph (iv) insert—
“(iva) the requirements of Schedule 12A (further provision as to the performance of pharmacovigilance activities);”.”;
(c) omit paragraphs (4) and (5).

---
Source: https://www.legislation.gov.uk/ukdsi/2020/9780348213980/schedule/2/paragraph/180 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-180
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.